Genmab A/S (GMAB)
35.32
+0.49
(+1.41%)
USD |
NASDAQ |
Sep 25, 16:00
35.30
-0.02
(-0.06%)
After-Hours: 19:59
Genmab Net Income (Annual) : 965.95M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 965.95M |
| December 31, 2024 | 1.138B |
| December 31, 2023 | 631.46M |
| December 31, 2022 | 770.21M |
| December 31, 2021 | 478.07M |
| December 31, 2020 | 727.60M |
| December 31, 2019 | 324.70M |
| December 31, 2018 | 233.02M |
| December 31, 2017 | 167.34M |
| December 31, 2016 | 176.37M |
| December 31, 2015 | 113.51M |
| December 31, 2014 | 53.61M |
| December 31, 2013 | 12.49M |
| December 31, 2012 | -19.23M |
| Date | Value |
|---|---|
| December 31, 2011 | -40.27M |
| December 31, 2010 | -25.43M |
| December 31, 2009 | -65.21M |
| December 31, 2008 | -161.12M |
| December 31, 2007 | -70.93M |
| December 31, 2006 | -74.34M |
| December 31, 2005 | -65.46M |
| December 31, 2004 | -71.01M |
| December 31, 2003 | -50.23M |
| December 31, 2002 | -61.32M |
| December 31, 2001 | -22.28M |
| December 31, 2000 | -4.491M |
| December 31, 1999 | -2.634M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| AbbVie, Inc. | 4.193B |
| Ascendis Pharma A/S | -257.35M |
| Zealand Pharma A/S | 976.11M |
| Bavarian Nordic A/S | 207.98M |
| Evaxion AS | -7.731M |